Based in Hyderabad, the Indian pharmaceutical manufacturing company, Granules India Limited announced the approval for Fexofenadine Hydrochloride tablets from the US Health regulator.
The tablet is allegedly used for treating allergy symptoms. According to sources, the tablets are bio-equivalent to the reference listed drug product (RLD), which are Allegra Allergy Tablets, 60 mg, 180 mg, of Sanofi-Aventis US LLC.
Moreover, ....
Tags : Granules India Limited, US Food & Drug Administration (USFDA), Fexofenadine Hydrochloride tablet,
comments (0)